Presentation and Status in Health Basket
| Presentation | Basket | Yarpa | Pharmasoft |
|---|---|---|---|
|
Capsules 0.5mg / 0.4 mg X 30 |
|
Dosage
One capsule taken once a day, 30 minutes after the same meal each day. Please refer to the license holder for further details.
Indications
Treatment of moderate to severe symptoms of benign prostatic hyperplasia (BPH). Reduction in the risk of acute urinary retention (AUR) and surgery in patients with moderate to severe symptoms of BPH.
Contra-Indications
– women, children and adolescents.
– patients with hypersensitivity to dutasteride, other 5-alpha reductase inhibitors, tamsulosin (including tamsulosin-induced angio-edema), soya, peanut or any of the other excipients.
– patients with a history of orthostatic hypotension.
– patients with severe hepatic impairment.
Special Precautions
Please refer to the license holder for further details.
Side Effects
Please refer to the license holder for further details.
Drug interactions
Please refer to the license holder for further details.
Pregnancy and Lactation
Please refer to the license holder for further details.
Overdose
Please refer to the license holder for further details.
Important notes
Please refer to the license holder for further details.
